BOLD Imaging in Awake Wild-Type and Mu-Opioid Receptor Knock-Out Mice Reveals On-Target Activation Maps in Response to Oxycodone

BOLD Imaging in Awake Wild-Type and Mu-Opioid Receptor Knock-Out Mice Reveals On-Target Activation Maps in Response to Oxycodone

Blood oxygen level dependent (BOLD) imaging in awake mice was used to identify differences in brain activity between wild-type, and Mu (µ) opioid receptor knock-outs (MuKO) in response to oxycodone (OXY). Using a segmented, annotated MRI mouse atlas and computational analysis, patterns of integrate...

Full description

Bibliographic Details
Main Authors:	Kelsey Moore, Dan Madularu, Sade Iriah, Jason Richard Yee, Praveen Kulkarni, Emmanuel Darcq, Brigitte L. Kieffer, Craig F Ferris
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-11-01
Series:	Frontiers in Neuroscience
Subjects:	Oxycodone Addiction knockout mouse mu-opioid receptor BOLD fMRI opioid receptors
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnins.2016.00471/full

Similar Items

The Role of Mu Opioid Receptors in High Fat Diet-Induced Reward and Potentiation of the Rewarding Effect of Oxycodone
by: Asif Iqbal, et al.
Published: (2023-02-01)

Chronic tianeptine induces tolerance in analgesia and hyperlocomotion via mu-opioid receptor activation in mice
by: Florence Allain, et al.
Published: (2023-05-01)

Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
by: Muzeyyen Ugur, et al.
Published: (2018-11-01)

Oxycodone regulates incision-induced activation of neurotrophic factors and receptors in an acute post-surgery pain rat model
by: Liu BW, et al.
Published: (2018-10-01)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
by: Keith M. Olson, et al.
Published: (2023-07-01)

Escalated Oxycodone Self-Administration and Punishment: Differential Expression of Opioid Receptors and Immediate Early Genes in the Rat Dorsal Striatum and Prefrontal Cortex
by: Christopher A. Blackwood, et al.
Published: (2020-01-01)

Deformation-based Morphometry MRI Reveals Brain Structural Modifications in Living Mu Opioid Receptor Knockout Mice
by: Md Taufiq Nasseef, et al.
Published: (2018-12-01)

Oxycodone, an opioid like the others?
by: Nicolas Marie, et al.
Published: (2023-12-01)

The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception
by: Pilar Sánchez-Blázquez, et al.
Published: (2020-11-01)

Population Pharmacokinetics of Oxycodone and Metabolites in Patients with Cancer-Related Pain
by: Bram C. Agema, et al.
Published: (2021-06-01)

Integrated Systems Analysis of Mixed Neuroglial Cultures Proteome Post Oxycodone Exposure
by: Rahul S. Guda, et al.
Published: (2021-06-01)

Role of efficacy as a determinant of locomotor activation by mu‐opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR‐selective phenylmorphans with high‐to‐low MOR efficacy
by: Edna J. Santos, et al.
Published: (2023-08-01)

Restless Leg Syndrome Induced by an Acute Withdrawal of Oxycodone
by: Joon Hyun Baek, et al.
Published: (2015-12-01)

Heteromerization of Endogenous Mu and Delta Opioid Receptors Induces Ligand-Selective Co-Targeting to Lysosomes
by: Lyes Derouiche, et al.
Published: (2020-09-01)

Analgesic Efficacy of Oxycodone in Postoperative Dressings after Surgical Treatment of Burn Wounds: A Randomised Controlled Trial
by: Grzegorz Kowalski, et al.
Published: (2024-01-01)

Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients
by: Guerriero F, et al.
Published: (2014-12-01)

Analgesic efficacy, adverse effects, and safety of oxycodone administered as continuous intravenous infusion in patients after total hip arthroplasty
by: Olczak B, et al.
Published: (2017-05-01)

Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu‐opioid receptor
by: Jia‐Jia Zhang, et al.
Published: (2022-09-01)

Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats
by: Jessica M. Illenberger, et al.
Published: (2023-04-01)

Molecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional Receptors
by: Edmund W. Ong, et al.
Published: (2014-03-01)

Effects of sex and estrous cycle on intravenous oxycodone self-administration and the reinstatement of oxycodone-seeking behavior in rats
by: Nicole M. Hinds, et al.
Published: (2023-07-01)

Synthesis, Biological Evaluation, and SAR Studies of 14β-phenylacetyl Substituted 17-cyclopropylmethyl-7, 8-dihydronoroxymorphinones Derivatives: Ligands With Mixed NOP and Opioid Receptor Profile
by: Vinod Kumar, et al.
Published: (2018-09-01)

Different neuronal populations mediate inflammatory pain analgesia by exogenous and endogenous opioids
by: Xin-Yan Zhang, et al.
Published: (2020-06-01)

Establishment to measure oxycodone in plasma with liquid chromatography–tandem mass spectrometry
by: Suguru Ito, et al.
Published: (2022-09-01)

Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene, <i>OPRM1</i>: Insight into Complex Mu Opioid Actions
by: Shan Liu, et al.
Published: (2021-10-01)

Efficacy and safety of controlled-release oxycodone for the management of moderate-to-severe chronic low back pain in Japan: results of an enriched enrollment randomized withdrawal study followed by an open-label extension study
by: Kawamata M, et al.
Published: (2019-01-01)

Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release product
by: Pergolizzi, J, et al.
Published: (2018-02-01)

Reward processing in schizophrenia and its relation to Mu opioid receptor availability and negative symptoms: A [11C]-carfentanil PET and fMRI study
by: Ekaterina Shatalina, et al.
Published: (2023-01-01)

Chronic oxycodone induces axonal degeneration in rat brain
by: Ruping Fan, et al.
Published: (2018-03-01)

Mu-opioid receptor and receptor tyrosine kinase crosstalk: Implications in mechanisms of opioid tolerance, reduced analgesia to neuropathic pain, dependence, and reward
by: Mackenzie C. Gamble, et al.
Published: (2022-12-01)

Mu opioid receptor mRNA overexpression predicts poor prognosis among 18 common solid cancers: A pan-cancer analysis
by: Wei Sun, et al.
Published: (2023-03-01)

Bifunctional Peptidomimetic G Protein-Biased Mu-Opioid Receptor Agonist and Neuropeptide FF Receptor Antagonist KGFF09 Shows Efficacy in Visceral Pain without Rewarding Effects after Subcutaneous Administration in Mice
by: Maria Dumitrascuta, et al.
Published: (2022-12-01)

Opioid suppression of an excitatory pontomedullary respiratory circuit by convergent mechanisms
by: Jordan T Bateman, et al.
Published: (2023-06-01)

Bias-inducing allosteric binding site in mu-opioid receptor signaling
by: Andrés F. Marmolejo-Valencia, et al.
Published: (2021-04-01)

Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model
by: Mitchell J. Bartlett, et al.
Published: (2020-03-01)

Comparison of the Rate of Mu Receptor Gene Single Nucleotide Polymorphism in Addicts and Non Addicts
by: N Ghasemi, et al.
Published: (2010-09-01)

Methylnaltrexone Treatment for Opioid-Induced Constipation in Patients with and without Cancer: Effect of Initial Dose
by: Chamberlain BH, et al.
Published: (2023-07-01)

Oliceridine: A Novel Drug for the Management of Moderate to Severe Acute Pain – A Review of Current Evidence
by: Tan HS, et al.
Published: (2021-04-01)

Heterodimerization of Mu Opioid Receptor Protomer with Dopamine D<sub>2</sub> Receptor Modulates Agonist-Induced Internalization of Mu Opioid Receptor
by: Lakshmi Vasudevan, et al.
Published: (2019-08-01)

Is oxycodone/naloxone effective and safe in managing chronic pain of a fragile elderly patient with multiple skin ulcers of the lower limbs? A case report 
by: Guerriero F, et al.
Published: (2015-08-01)